[Neurotoxicity of antiviral agents].
Kanemitsu
K
K
Department of Microbiology, St. Marianna University School of Medicine.
Ikejima
H
H
Shimada
J
J
D000212:Acyclovir / Q000009:adverse effects; D000547:Amantadine / Q000009:adverse effects; D000998:Antiviral Agents / Q000009:adverse effects*; D002493:Central Nervous System Diseases / Q000139:chemically induced*; D015774:Ganciclovir / Q000009:adverse effects; D006801:Humans; D012299:Rimantadine / Q000009:adverse effects; D014740:Vidarabine / Q000009:adverse effects
D000998:Antiviral Agents; D012299:Rimantadine; D000547:Amantadine; D014740:Vidarabine; D015774:Ganciclovir; D000212:Acyclovir